$EBS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Emergent BioSolutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Emergent BioSolutions Inc.. Get notifications about new insider transactions in Emergent BioSolutions Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 61.62 | 1,054 | 64,947 | 36,919 | 38 K to 36.9 K (-2.78 %) |
May 11 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 61.62 | 94 | 5,792 | 163,053 | 163.1 K to 163.1 K (-0.06 %) |
May 11 2021 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 18.64 | 10,305 | 192,085 | 0 | |
May 11 2021 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Payment of Exercise | F | 61.62 | 3,118 | 192,131 | 39,945 | 43.1 K to 39.9 K (-7.24 %) |
May 11 2021 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 18.64 | 10,305 | 192,085 | 43,063 | 32.8 K to 43.1 K (+31.46 %) |
Apr 01 2021 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Payment of Exercise | F | 0.00 | 159 | 0 | 17,776 | 17.9 K to 17.8 K (-0.89 %) |
Mar 08 2021 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 92.37 | 8,168 | 754,478 | 24,427 | 32.6 K to 24.4 K (-25.06 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 13,906 | 0 | 13,906 | |
Feb 26 2021 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 93.49 | 27,808 | 2,599,770 | 27,808 | |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Option Exercise | A | 93.49 | 59,898 | 5,599,864 | 59,898 | |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 97.15 | 860 | 83,549 | 163,147 | 164 K to 163.1 K (-0.52 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 97.15 | 1,716 | 166,709 | 164,007 | 165.7 K to 164 K (-1.04 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 93.49 | 2,425 | 226,713 | 165,723 | 168.1 K to 165.7 K (-1.44 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 14,975 | 0 | 168,148 | 153.2 K to 168.1 K (+9.78 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 14,975 | 0 | 153,173 | 138.2 K to 153.2 K (+10.84 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Smith Karen L. | EVP, Chief Medical ... | Option Exercise | A | 93.49 | 11,765 | 1,099,910 | 11,765 | |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Smith Karen L. | EVP, Chief Medical ... | Grant | A | 0.00 | 2,941 | 0 | 12,193 | 9.3 K to 12.2 K (+31.79 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | Smith Karen L. | EVP, Chief Medical ... | Grant | A | 0.00 | 2,942 | 0 | 9,252 | 6.3 K to 9.3 K (+46.62 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Option Exercise | A | 93.49 | 16,043 | 1,499,860 | 16,043 | |
Feb 26 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 97.15 | 819 | 79,566 | 37,973 | 38.8 K to 38 K (-2.11 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 93.49 | 1,010 | 94,425 | 38,792 | 39.8 K to 38.8 K (-2.54 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 4,012 | 0 | 39,802 | 35.8 K to 39.8 K (+11.21 %) |
Feb 26 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 4,011 | 0 | 35,790 | 31.8 K to 35.8 K (+12.62 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 123.45 | 2,183 | 269,491 | 33,020 | 35.2 K to 33 K (-6.20 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Grant | A | 0.00 | 2,518 | 0 | 35,203 | 32.7 K to 35.2 K (+7.70 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Payment of Exercise | F | 123.45 | 2,430 | 299,984 | 39,722 | 42.2 K to 39.7 K (-5.76 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 2,656 | 0 | 42,152 | 39.5 K to 42.2 K (+6.72 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 123.45 | 423 | 52,219 | 138,198 | 138.6 K to 138.2 K (-0.31 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 323 | 0 | 138,621 | 138.3 K to 138.6 K (+0.23 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 123.45 | 3,870 | 477,752 | 138,298 | 142.2 K to 138.3 K (-2.72 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 2,958 | 0 | 142,168 | 139.2 K to 142.2 K (+2.12 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 123.45 | 2,042 | 252,085 | 27,981 | 30 K to 28 K (-6.80 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Grant | A | 0.00 | 2,014 | 0 | 30,023 | 28 K to 30 K (+7.19 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 123.45 | 2,522 | 311,341 | 31,779 | 34.3 K to 31.8 K (-7.35 %) |
Feb 11 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 2,495 | 0 | 34,301 | 31.8 K to 34.3 K (+7.84 %) |
Feb 09 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Option Exercise | M | 30.63 | 13,000 | 398,190 | 19,638 | |
Feb 09 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Option Exercise | M | 30.86 | 32,397 | 999,771 | 0 | |
Feb 09 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Sell | S | 120.03 | 13,000 | 1,560,390 | 139,210 | 152.2 K to 139.2 K (-8.54 %) |
Feb 09 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Buy | M | 30.63 | 13,000 | 398,190 | 152,210 | 139.2 K to 152.2 K (+9.34 %) |
Feb 09 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Sell | S | 120.03 | 32,397 | 3,888,612 | 139,210 | 171.6 K to 139.2 K (-18.88 %) |
Feb 09 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Buy | M | 30.86 | 32,397 | 999,771 | 171,607 | 139.2 K to 171.6 K (+23.27 %) |
Jan 22 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Option Exercise | M | 26.45 | 21,900 | 579,255 | 0 | |
Jan 22 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Option Exercise | M | 26.45 | 2,232 | 59,036 | 21,900 | |
Jan 22 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Sell | S | 110.03 | 21,900 | 2,409,657 | 139,210 | 161.1 K to 139.2 K (-13.59 %) |
Jan 22 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Buy | M | 26.45 | 21,900 | 579,255 | 161,110 | 139.2 K to 161.1 K (+15.73 %) |
Jan 22 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Sell | S | 110.00 | 2,232 | 245,520 | 139,210 | 141.4 K to 139.2 K (-1.58 %) |
Jan 22 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Buy | M | 26.45 | 2,232 | 59,036 | 141,442 | 139.2 K to 141.4 K (+1.60 %) |
Jan 19 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Option Exercise | M | 25.62 | 19,026 | 487,446 | 0 | |
Jan 19 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Sell | S | 106.01 | 19,026 | 2,016,901 | 139,210 | 158.2 K to 139.2 K (-12.02 %) |
Jan 19 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Buy | M | 25.62 | 19,026 | 487,446 | 158,236 | 139.2 K to 158.2 K (+13.67 %) |
Nov 12 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 26.45 | 19,391 | 512,892 | 0 | |
Nov 12 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 26.45 | 20,000 | 529,000 | 19,391 | |
Nov 12 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 88.21 | 19,391 | 1,710,480 | 1,123,988 | 1.1 M to 1.1 M (-1.70 %) |
Nov 12 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 26.45 | 19,391 | 512,892 | 1,143,379 | 1.1 M to 1.1 M (+1.73 %) |
Nov 12 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 95.26 | 20,000 | 1,905,200 | 1,123,988 | 1.1 M to 1.1 M (-1.75 %) |
Nov 12 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 26.45 | 20,000 | 529,000 | 1,143,988 | 1.1 M to 1.1 M (+1.78 %) |
Nov 04 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 26.45 | 20,000 | 529,000 | 39,391 | |
Nov 04 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 26.45 | 20,000 | 529,000 | 59,391 | |
Nov 04 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 90.74 | 20,000 | 1,814,800 | 1,123,988 | 1.1 M to 1.1 M (-1.75 %) |
Nov 04 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 26.45 | 20,000 | 529,000 | 1,143,988 | 1.1 M to 1.1 M (+1.78 %) |
Nov 04 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 90.44 | 20,000 | 1,808,800 | 1,123,988 | 1.1 M to 1.1 M (-1.75 %) |
Nov 04 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 26.45 | 20,000 | 529,000 | 1,143,988 | 1.1 M to 1.1 M (+1.78 %) |
Sep 25 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 98.85 | 12,535 | 1,239,085 | 1,123,988 | 1.1 M to 1.1 M (-1.10 %) |
Sep 25 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 100.58 | 13,000 | 1,307,540 | 1,136,523 | 1.1 M to 1.1 M (-1.13 %) |
Sep 18 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 100.68 | 20,000 | 2,013,600 | 1,149,523 | 1.2 M to 1.1 M (-1.71 %) |
Sep 18 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 102.48 | 20,000 | 2,049,600 | 1,169,523 | 1.2 M to 1.2 M (-1.68 %) |
Sep 18 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Gift | G | 0.00 | 10,004 | 0 | 32,758 | 42.8 K to 32.8 K (-23.39 %) |
Sep 11 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 102.66 | 20,000 | 2,053,200 | 1,189,523 | 1.2 M to 1.2 M (-1.65 %) |
Sep 11 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 102.66 | 20,000 | 2,053,200 | 1,189,523 | 1.2 M to 1.2 M (-1.65 %) |
Sep 11 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 102.80 | 20,000 | 2,056,000 | 1,209,523 | 1.2 M to 1.2 M (-1.63 %) |
Sep 11 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 102.80 | 20,000 | 2,056,000 | 1,209,523 | 1.2 M to 1.2 M (-1.63 %) |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 20.08 | 7,893 | 158,491 | 15,786 | |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 20.08 | 7,893 | 158,491 | 15,786 | |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 111.23 | 7,893 | 877,904 | 42,762 | 50.7 K to 42.8 K (-15.58 %) |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 111.23 | 7,893 | 877,904 | 42,762 | 50.7 K to 42.8 K (-15.58 %) |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 20.08 | 7,893 | 158,491 | 50,655 | 42.8 K to 50.7 K (+18.46 %) |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 20.08 | 7,893 | 158,491 | 50,655 | 42.8 K to 50.7 K (+18.46 %) |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 111.22 | 20,525 | 2,282,702 | 42,762 | 63.3 K to 42.8 K (-32.43 %) |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 111.22 | 20,525 | 2,282,702 | 42,762 | 63.3 K to 42.8 K (-32.43 %) |
Aug 19 2020 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 128.31 | 4,665 | 598,564 | 32,595 | 37.3 K to 32.6 K (-12.52 %) |
Aug 18 2020 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Sell | S | 133.71 | 6,609 | 883,664 | 24,579 | 31.2 K to 24.6 K (-21.19 %) |
Aug 12 2020 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Sell | S | 124.11 | 6,000 | 744,635 | 26,771 | 32.8 K to 26.8 K (-18.31 %) |
Aug 11 2020 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Payment of Exercise | F | 126.96 | 1,303 | 165,429 | 39,496 | 40.8 K to 39.5 K (-3.19 %) |
Aug 11 2020 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Payment of Exercise | F | 126.96 | 1,303 | 165,429 | 39,496 | 40.8 K to 39.5 K (-3.19 %) |
Aug 11 2020 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 131.00 | 6,297 | 824,907 | 8,276 | 14.6 K to 8.3 K (-43.21 %) |
Aug 11 2020 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 131.00 | 6,297 | 824,907 | 8,276 | 14.6 K to 8.3 K (-43.21 %) |
Aug 11 2020 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Sell | S | 130.27 | 1,000 | 130,270 | 12,489 | 13.5 K to 12.5 K (-7.41 %) |
Aug 11 2020 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Sell | S | 130.27 | 1,000 | 130,270 | 12,489 | 13.5 K to 12.5 K (-7.41 %) |
Jun 05 2020 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 87.51 | 6,572 | 575,142 | 4,269 | 10.8 K to 4.3 K (-60.62 %) |
Jun 05 2020 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 87.50 | 5,322 | 465,691 | 37,260 | 42.6 K to 37.3 K (-12.50 %) |
May 27 2020 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Sell | S | 85.15 | 4,385 | 373,373 | 10,188 | 14.6 K to 10.2 K (-30.09 %) |
May 27 2020 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Sell | S | 85.10 | 4,093 | 348,322 | 13,489 | 17.6 K to 13.5 K (-23.28 %) |
May 26 2020 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Grant | A | 0.00 | 2,821 | 0 | 17,582 | 14.8 K to 17.6 K (+19.11 %) |
May 26 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 2,821 | 0 | 63,287 | 60.5 K to 63.3 K (+4.67 %) |
May 26 2020 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Grant | A | 0.00 | 2,821 | 0 | 10,841 | 8 K to 10.8 K (+35.17 %) |
May 26 2020 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Grant | A | 0.00 | 2,821 | 0 | 32,771 | 30 K to 32.8 K (+9.42 %) |
May 26 2020 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Grant | A | 0.00 | 2,821 | 0 | 14,573 | 11.8 K to 14.6 K (+24.00 %) |
May 26 2020 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Grant | A | 0.00 | 2,821 | 0 | 31,188 | 28.4 K to 31.2 K (+9.94 %) |
May 26 2020 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Grant | A | 0.00 | 2,821 | 0 | 42,582 | 39.8 K to 42.6 K (+7.09 %) |
May 18 2020 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Option Exercise | M | 18.64 | 3,434 | 64,010 | 0 | |
May 18 2020 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Buy | M | 18.64 | 3,434 | 64,010 | 28,367 | 24.9 K to 28.4 K (+13.77 %) |
May 13 2020 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Sell | S | 81.99 | 4,940 | 405,025 | 24,933 | 29.9 K to 24.9 K (-16.54 %) |
May 13 2020 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Sell | S | 85.19 | 2,000 | 170,371 | 29,950 | 32 K to 30 K (-6.26 %) |
May 12 2020 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 79.25 | 237 | 18,782 | 28,009 | 28.2 K to 28 K (-0.84 %) |
May 12 2020 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 79.25 | 95 | 7,529 | 142,203 | 142.3 K to 142.2 K (-0.07 %) |
May 12 2020 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 79.25 | 728 | 57,694 | 31,806 | 32.5 K to 31.8 K (-2.24 %) |
May 06 2020 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 80.19 | 8,375 | 671,629 | 8,020 | 16.4 K to 8 K (-51.08 %) |
May 01 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 74.01 | 20,000 | 1,480,200 | 1,229,523 | 1.2 M to 1.2 M (-1.60 %) |
May 01 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 74.24 | 20,000 | 1,484,800 | 1,249,523 | 1.3 M to 1.2 M (-1.58 %) |
Apr 29 2020 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 20.08 | 7,893 | 158,491 | 0 | |
Apr 29 2020 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 78.00 | 7,893 | 615,654 | 16,395 | 24.3 K to 16.4 K (-32.50 %) |
Apr 29 2020 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 20.08 | 7,893 | 158,491 | 24,288 | 16.4 K to 24.3 K (+48.14 %) |
Apr 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 68.49 | 20,000 | 1,369,800 | 1,269,523 | 1.3 M to 1.3 M (-1.55 %) |
Apr 24 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 66.81 | 20,000 | 1,336,200 | 1,289,523 | 1.3 M to 1.3 M (-1.53 %) |
Apr 21 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | S | 30.86 | 17,009 | 524,898 | 80,384 | |
Apr 21 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | S | 26.45 | 20,414 | 539,950 | 97,393 | |
Apr 21 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 69.00 | 17,009 | 1,173,621 | 34,256 | 51.3 K to 34.3 K (-33.18 %) |
Apr 21 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Buy | M | 30.86 | 17,009 | 524,898 | 51,265 | 34.3 K to 51.3 K (+49.65 %) |
Apr 21 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 65.00 | 20,414 | 1,326,910 | 34,256 | 54.7 K to 34.3 K (-37.34 %) |
Apr 21 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Buy | M | 26.45 | 20,414 | 539,950 | 54,670 | 34.3 K to 54.7 K (+59.59 %) |
Apr 20 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 62.47 | 20,000 | 1,249,400 | 1,309,523 | 1.3 M to 1.3 M (-1.50 %) |
Apr 15 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 62.58 | 12,537 | 784,565 | 1,329,523 | 1.3 M to 1.3 M (-0.93 %) |
Apr 15 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 62.99 | 6,261 | 394,380 | 1,342,060 | 1.3 M to 1.3 M (-0.46 %) |
Apr 15 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 62.25 | 17,071 | 1,062,670 | 1,348,321 | 1.4 M to 1.3 M (-1.25 %) |
Apr 10 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 61.83 | 23,716 | 1,466,360 | 1,365,392 | 1.4 M to 1.4 M (-1.71 %) |
Apr 10 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 61.83 | 23,716 | 1,466,360 | 1,365,392 | 1.4 M to 1.4 M (-1.71 %) |
Apr 10 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 61.34 | 24,362 | 1,494,365 | 1,389,108 | 1.4 M to 1.4 M (-1.72 %) |
Apr 10 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 61.34 | 24,362 | 1,494,365 | 1,389,108 | 1.4 M to 1.4 M (-1.72 %) |
Apr 10 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 60.75 | 13,000 | 789,750 | 1,413,470 | 1.4 M to 1.4 M (-0.91 %) |
Apr 10 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 60.75 | 13,000 | 789,750 | 1,413,470 | 1.4 M to 1.4 M (-0.91 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 60.76 | 14,336 | 871,055 | 1,426,470 | 1.4 M to 1.4 M (-0.99 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 60.50 | 28,240 | 1,708,520 | 1,440,806 | 1.5 M to 1.4 M (-1.92 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 60.76 | 14,336 | 871,055 | 1,426,470 | 1.4 M to 1.4 M (-0.99 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 60.50 | 28,240 | 1,708,520 | 1,440,806 | 1.5 M to 1.4 M (-1.92 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 60.00 | 3,730 | 223,800 | 34,256 | 38 K to 34.3 K (-9.82 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 60.00 | 4,242 | 254,520 | 37,986 | 42.2 K to 38 K (-10.05 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Option Exercise | S | 30.63 | 7,293 | 223,385 | 31,512 | |
Apr 08 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Option Exercise | S | 30.86 | 3,135 | 96,746 | 38,805 | |
Apr 08 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Sell | S | 60.00 | 7,293 | 437,580 | 12,571 | 19.9 K to 12.6 K (-36.71 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Buy | M | 30.63 | 7,293 | 223,385 | 19,864 | 12.6 K to 19.9 K (+58.01 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Sell | S | 60.00 | 3,135 | 188,100 | 12,571 | 15.7 K to 12.6 K (-19.96 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Buy | M | 30.86 | 3,135 | 96,746 | 15,706 | 12.6 K to 15.7 K (+24.94 %) |
Apr 08 2020 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Sell | S | 60.00 | 5,666 | 339,960 | 12,571 | 18.2 K to 12.6 K (-31.07 %) |
Mar 17 2020 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Sell | S | 65.00 | 6,400 | 416,000 | 29,873 | 36.3 K to 29.9 K (-17.64 %) |
Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 13.00 | 7,893 | 102,609 | 0 | |
Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 14.71 | 7,893 | 116,106 | 0 | |
Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 58.96 | 7,893 | 465,357 | 60,466 | 68.4 K to 60.5 K (-11.55 %) |
Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 14.71 | 7,893 | 116,106 | 68,359 | 60.5 K to 68.4 K (+13.05 %) |
Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 58.96 | 7,893 | 465,357 | 60,466 | 68.4 K to 60.5 K (-11.55 %) |
Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 13.00 | 7,893 | 102,609 | 68,359 | 60.5 K to 68.4 K (+13.05 %) |